Paolo Falvo

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Targeting DNA interstrand crosslinks repair with synthetic lethality in High-Grade B-Cell Lymphoma.

Targeting DNA interstrand crosslinks repair with synthetic lethality in High-Grade B-Cell Lymphoma.

Journal: Leukemia

Published: September 10, 2025

Myeloid-Derived Suppressor Cells (MDSCs) at the Crossroad of Senescence and Cancer.

Myeloid-Derived Suppressor Cells (MDSCs) at the Crossroad of Senescence and Cancer.

Journal: Cancers

Published: June 05, 2025

The Arming of Natural Killer Cells With Fc-Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells.

The Arming of Natural Killer Cells With Fc-Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells.

Journal: MedComm

Published: September 02, 2024

Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma.

Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma.

Journal: iScience

Published: August 19, 2024

HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients.

HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients.

Journal: Discover oncology

Published: August 09, 2024

Age-dependent differences in breast tumor microenvironment: challenges and opportunities for efficacy studies in preclinical models.

Age-dependent differences in breast tumor microenvironment: challenges and opportunities for efficacy studies in preclinical models.

Journal: Cell death and differentiation

Published: February 19, 2024

Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia.

Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia.

Journal: Nature communications

Published: October 01, 2023

Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion.

Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion.

Journal: Nature communications

Published: August 07, 2023

Metronomic chemotherapy, dampening of immunosuppressive cells, antigen presenting cell activation, and T cells. A quartet against refractoriness and resistance to checkpoint inhibitors.

Metronomic chemotherapy, dampening of immunosuppressive cells, antigen presenting cell activation, and T cells. A quartet against refractoriness and resistance to checkpoint inhibitors.

Journal: Cancer letters

Published: August 03, 2023

High-Fat Diet Promotes Acute Promyelocytic Leukemia through PPARδ-Enhanced Self-renewal of Preleukemic Progenitors.

High-Fat Diet Promotes Acute Promyelocytic Leukemia through PPARδ-Enhanced Self-renewal of Preleukemic Progenitors.

Journal: Cancer prevention research (Philadelphia, Pa.)

Published: June 15, 2023

BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3.

BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3.

Journal: Nature communications

Published: March 31, 2023

Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge.

Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge.

Journal: Journal of clinical medicine

Published: February 02, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026